Q

    Quoin Pharmaceuticals Ltd DRC (QNRX)

    Official site

    HEALTHCARE • BIOTECHNOLOGY • NASDAQ

    $6.22
    +0.10 (+1.63%)

    Market Cap: $12.29M

    Last updated: Sep 01, 2026 at 10:00 AM ET

    Earnings

    Performance (10Y)

    Beat Rate
    61%(17/28)
    Avg Surprise
    -1634.67%

    Upcoming Estimates

    Sep 30, 2026
    EPS Consensus$-1.76
    Range$-2.05 - $-1.47
    2 analysts
    EPS RevisionsNo revisions (7d)No revisions (30d)
    EPS Estimate Drift
    90d ago$-1.32+25.0%
    60d ago$-1.69+4.3%
    30d ago$-1.69+4.3%
    7d ago$-1.69+4.3%
    Current$-1.76
    Revenue Consensus
    $0
    Range$0 - $0
    4 analysts
    Dec 31, 2026
    EPS Consensus$-1.38
    Range$-2.10 - $-0.66
    2 analysts
    Revenue Consensus
    $0
    Range$0 - $0
    4 analysts
    PeriodReportedEst.SurpriseB/MYoY
    Dec 26EST
    		-$-1.38---
    Sep 26EST
    		-$-1.76---
    Jun 26
    		$-1.90$-1.83-3.83%Miss+69.7%
    Mar 26
    		$-1.77$-2.26+21.68%Beat+72.8%
    Dec 25
    		$-1.74N/A+56.72%Beat-525.7%
    Sep 25
    		$-6.70$-1.92-248.96%Miss+59.4%
    Jun 25
    		$-6.28$-6.83+8.05%Beat+54.1%
    Mar 25
    		$-6.50$-4.20-54.76%Miss+83.2%
    Dec 24
    		$-0.28$-0.43+35.33%Beat+86.6%
    Sep 24
    		$-16.51$-0.40-4027.50%Miss+75.8%
    Jun 24
    		$-13.67$-20.30+32.66%Beat+81.4%
    Mar 24
    		$-38.62$-14.35-169.13%Miss+73.2%
    Dec 23
    		$-2.08$-2.31+9.96%Beat-407.3%
    Sep 23
    		$-68.25$-95.32+28.40%Beat+82.7%
    Jun 23
    		$-73.48$-96.60+23.93%Beat+94.6%
    Mar 23
    		$-144.10$-96.60-49.17%Miss-100.6%
    Dec 22
    		$-0.41$-0.62+33.87%Beat+99.9%
    Sep 22
    		$-395.26$-495.60+20.25%Beat+94.7%
    Jun 22
    		$-1360.80$-1158.15-17.50%Miss-755900.0%
    Mar 22
    		$22207.53$-4392.51+605.58%Beat+1272081.8%
    Dec 21
    		$-309.00$-0.73-41940.82%Miss-772400.0%
    Sep 21
    		$-7402.51$-1365.00-442.31%Miss-74025000.0%
    Jun 21
    		$-0.18N/AN/ABeat-350.0%
    Mar 21
    		$-1.75$0.00N/AMiss-17359.0%
    Dec 20
    		$-0.04$0.00N/AMiss+95.5%
    Sep 20
    		$-0.01$0.00N/AMiss+99.7%
    Jun 20
    		$-0.04$0.00N/AMiss+98.4%
    Mar 20
    		$-0.01$0.00N/AMiss+97.5%
    Dec 19
    		$-0.89$0.00N/AMiss+72.0%
    Sep 19
    		$-3.14$0.00N/AMiss+95.7%
    Jun 19
    		$-2.47$0.00N/AMiss+96.0%
    Mar 19
    		$-0.41$0.00N/AMiss+99.0%
    Dec 18
    		$-3.17$0.00N/AMiss+92.1%
    Sep 18
    		$-72.50$-70.00-3.57%Miss+26.0%
    Jun 18
    		$-62.50$-72.50+13.79%Beat-1853.1%
    Mar 18
    		$-40.00$-75.00+46.67%Beat-170.3%
    Dec 17
    		$-40.00$-77.50+48.39%Beat-128.6%
    Sep 17
    		$-98.00$-75.00-30.67%Miss-1532.4%
    Jun 17
    		$-3.20N/A+94.18%Beat-
    Mar 17
    		$-14.80N/A+73.09%Beat-
    Dec 16
    		$-17.50N/A+65.00%Beat-
    Sep 16
    		$-6.00N/AN/ABeat-

    Key Metrics

    Valuation
    P/E Ratio-0.51EV/EBITDA-0.42x
    Price/FCFN/AFCF YieldN/A
    Profitability
    Profit Margin0.00%Operating Margin0.00%
    ROE-576.00%ROICN/A
    Financial Health
    Debt/EquityN/AInterest CoverageN/A
    Current Ratio1.76xQuick Ratio1.76x
    Trading Statistics
    Beta1.66Avg Volume1.53M
    52-Week High$23.5052-Week Low$3.25

    Technical Indicators Dashboard

    Moving Averages

    SMA 10$5.34
    SMA 20$5.22
    SMA 50$4.70
    SMA 200$8.09
    EMA 10$5.50
    EMA 20$5.25
    EMA 50$5.03
    EMA 200$6.82

    MACD

    Line: 0.29Signal: 0.21Hist: 0.08

    ADX

    ADX: 26.3+DI: 44.4-DI: 19.8

    Aroon & PSAR

    Aroon Up96.0
    Aroon Down12.0
    PSAR$4.67

    Bollinger Bands

    Upper Band$6.31
    Lower Band$4.13
    %B Position4176%(Upper)
    Band Width0.96

    RSI (14-Day)

    Neutral
    65.8

    Momentum Oscillators

    Stoch %K40.2
    Stoch %D37.1
    Williams %R-54.9
    ROC (10d)19.8%
    Momentum1.03
    CCI (20d)127.5
    MFI (14d)98.1

    Volatility Measures

    ATR (14d)$0.73(11.7%)
    StdDev (20d)0.55
    Hist Vol120.6%(High)

    Volume Flow

    VWAP$6.07
    OBV272.9M
    AD Line66.6B
    CMF (20d)-0.813

    Volume Metrics

    Avg Vol (20d)1.6M
    Vol Ratio0.4x(Low)
    VWMA (20d)$6.11

    Pivot Points

    R3$9.90
    R2$9.07
    R1$7.60
    Pivot Point$6.77
    S1$5.30
    S2$4.47
    S3$3.00

    Advanced Oscillators

    TSI17.68
    Ultimate Osc47.3
    KST194.25

    Financial Data

    QuarterJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023Sep 2023
    Total RevenueN/A$0$0$0$0$0$100,370$0$0$0$154,774$0
    Cost of Revenue$25,429$24,932$25,156N/A$25,520$24,870$25,199$25,074$24,908$25,277$25,952$25,915
    Gross Profit$-25,429$-24,932$-25,156N/A$-25,520$-24,870$50,185$-25,074$-24,908$-25,277$-25,952$-25,915
    Operating Expenses$5.54M$5.13M$4.52M$4.02M$3.79M$3.96M$2.41M$2.53M$2.14M$2.46M$2.22M$2.13M
    R&D$3.66M$3.43M$3.10M$2.28M$2.05M$2.37M$1.07M$1.17M$587,503$885,298$832,391$758,759
    SG&A$0$1.70M$1.42M$1.74M$1.74M$1.58M$1.33M$1.36M$1.55M$1.57M$1.39M$1.37M
    Operating Income$-5,567,562$-5,131,210$-4,520,435$-4,019,925$-3,793,179$-3,957,177$-2,405,061$-2,528,002$-2,137,118$-2,458,284$-2,217,667$-2,125,223
    Interest Income$0$146,775$171,698$62,266$103,245$144,872$109,328$146,388$165,262$137,513$158,546$196,425
    Interest Expense$0$0$0$0$0$0$0$0$0$0$218,919$0
    Income Before Tax$-5,463,270$-4,997,735$-4,348,373$-3,948,165$-3,695,938$-3,812,179$-2,311,274$-2,349,885$-1,974,033$-2,327,280$-2,049,878$-1,926,679
    Income Tax Expense$0$0$0$0$0$0$-1,966,838$-8,953,466,991$1.97M$2$2.07M$-23,891
    Net Income$-5,463,270$-4,997,735$-4,348,373$-3,948,165$-3,695,938$-3,812,179$-2,311,274$-2,349,885$-1,974,033$-2,327,280$-2,049,878$-1,926,679
    EBITDA$-5,542,133$-5,117,910$-4,323,373$-3,923,165$-3,670,938$-3,787,179$-2,286,274$-2,324,885$-1,949,033$-2,302,280$-2,024,204$-1,900,669
    EBIT$-5,567,562$-4,984,187$-4,348,373$-3,948,165$-3,695,938$-3,812,179$-2,311,274$-2,349,885$-1,974,033$-2,327,280$-2,049,878$-1,926,679
    * Some calculated fields are derived from available data when not provided by source

    Related GNG Research

    No research available

    Be the first to write about QNRX

    News

    Quoin Pharmaceuticals | 8-K: Current report

    This article is a current report filed by Quoin Pharmaceuticals as an 8-K document. The content of the report indicates standard corporate disclosure, likely concerning significant events required by regulatory bodies.

    Moomoo•8/21/26•
    Neutral

    Quoin Pharma (NASDAQ: QNRX) lifts board pay ceiling to $250K plus options

    Quoin Pharmaceuticals (NASDAQ: QNRX) shareholders approved significant changes to their non-employee director compensation program at the 2026 Annual General Meeting. The amendments raise the annual base cash retainer to a maximum of $250,000 and set an annual option award value range between $20,000 and $200,000, with specific amounts determined by the Compensation Committee and Board. Shareholders also approved changes to the Company's 401(k) plan matching contributions and re-elected several directors.

    Stock Titan•8/20/26•
    Neutral

    Price to book forward of Quoin Pharmaceuticals, Ltd. – NASDAQ:QNRX

    The article displays the "Price to book forward" for Quoin Pharmaceuticals, Ltd. (NASDAQ: QNRX) as provided by TradingView. It indicates that the market was closed and no trades were made at the time of publication. The content primarily focuses on financial data presentation within the TradingView platform.

    TradingView•8/16/26•
    Neutral

    8-K: Quoin Pharmaceuticals Provides Corporate Update and Reports Second Quarter 2026 Financial Results - moomoo

    Quoin Pharmaceuticals has provided a corporate update and released its financial results for the second quarter of 2026. This announcement likely includes key operational highlights, advancements in its product pipeline, and financial performance data, offering insights into the company's progress and future outlook. Investors and stakeholders will be keen to review this information to assess the company's health and strategic direction.

    Moomoo•8/15/26•
    Neutral

    Quoin Pharmaceuticals | 10-Q: Quarterly report

    This document is a quarterly report (10-Q) filed by Quoin Pharmaceuticals. It contains financial statements and other important disclosures required by the Securities and Exchange Commission for the reporting period.

    Moomoo•8/15/26•
    Neutral

    Frequently Asked Questions About QNRX

    Does QNRX pay dividends?
    Quoin Pharmaceuticals Ltd DRC (QNRX) does not currently pay a regular dividend.
    What is QNRX's market cap?
    Quoin Pharmaceuticals Ltd DRC (QNRX) has a market capitalization of $12.29M with a current stock price of $6.22.

    Get full access to GNG Research

    Create a free account to access portfolio tracking, advanced tools, and more.

    Create Free AccountLog In